Titamed

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	29-07-2025	2 d early	2025-00326532
31-12-2023	31-07-2024	31-08-2024	31 d late	2024-00448016
31-12-2022	31-07-2023	27-07-2023	4 d early	2023-00287573
31-12-2021	31-07-2022	25-06-2022	36 d early	2022-20091904
31-12-2020	31-07-2021	26-07-2021	5 d early	2021-39800500
31-12-2019	31-07-2020	07-07-2020	24 d early	2020-26600107
31-12-2018	31-07-2019	26-08-2019	26 d late	2019-50700472
31-12-2017	31-07-2018	18-07-2018	13 d early	2018-33400061
31-12-2016	31-07-2017	09-08-2017	9 d late	2017-41700484
31-12-2015	31-07-2016	04-08-2016	4 d late	2016-40800353

Fiscal year	Type	Filed	Reference
31-12-2024	verkort	29-07-2025	2025-00326532
31-12-2023	verkort	31-08-2024	2024-00448016
31-12-2022	verkort	27-07-2023	2023-00287573
31-12-2021	verkort	25-06-2022	2022-20091904
31-12-2020	verkort	26-07-2021	2021-39800500
31-12-2019	verkort	07-07-2020	2020-26600107
31-12-2018	verkort	26-08-2019	2019-50700472
31-12-2017	verkort	18-07-2018	2018-33400061
31-12-2016	verkort	09-08-2017	2017-41700484
31-12-2015	verkort	04-08-2016	2016-40800353

NACE primary	Vervaardiging van overige farmaceutische producten(21209)
Legal form	Private limited company(610)
Incorporation	16-07-2004
Status	Active
Postal code	2550

Summary